Purity, ID & Quantitation
View the analytical report assigned to this product option.
View COA↗Imagine First
PT-141
PT-141
Regular price
$49.00
Regular price
Sale price
$49.00
Quantity
Couldn't load pickup availability
PT-141 is a synthetic cyclic peptide studied in controlled laboratory models involving melanocortin-receptor signaling and neuroendocrine pathways. Supplied as a clearly labeled 10 mg lyophilized research material.
Choose one vial or save 10% with a three-vial option. Variant-specific analytical documentation can be viewed through the COA section when available.
For laboratory research use only.
Documentation
Certificate of Analysis
Select a product option to view its available documentation.
Endotoxin
View the endotoxin report assigned to this product option.
View COA↗Documentation applies only to the product option and lot identified in each report.
Research overview
A cyclic melanocortin peptide with a defined receptor-pharmacology research history.
Educational context is separated from the current-batch analytical documentation for the supplied material.
Literature nameBremelanotide is the established name used in published research.
Peptide classCyclic melanocortin analog derived from melanotan-II research.
Receptor contextLiterature discusses agonist activity across melanocortin receptor subtypes.
Research codePT-141
Literature nameBremelanotide
Presentation10MG
Material formLyophilized powder
Compound Profile & Technical Overview
PT-141 is the research code associated with bremelanotide, a cyclic melanocortin peptide. Published work characterizes its interaction with melanocortin receptor systems and distinguishes its central signaling research from peripheral vascular mechanisms. This 10MG lyophilized presentation is supplied for laboratory research only, with identity and quality defined by the current lot documentation.
Storage requirements
Protect from lightKeep refrigerated after reconstitutionAvoid freeze/thaw cycles
Lyophilized powder-20°CStated stability: 24+ months
Reconstituted solution2-8°CStated stability: approximately 30 days
Sealed lyophilized vials are described as heat-stable; refrigeration or freezing of sealed vials is optional. The 2-8°C guidance applies after reconstitution. Always follow the lot-specific documentation when it differs.
Published Research & References
Research resources: indexed PT-141 and bremelanotide literature. Linked literature is provided for educational context and does not establish identity, safety, efficacy, or expected outcomes for independently supplied material.
Important research notice
This material is offered strictly for laboratory research use. It is not intended for human or veterinary use, food use, compounding, diagnosis, treatment, cure, or prevention of disease. Published findings are contextual and do not establish equivalence to this independently supplied material.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, FOOD, COSMETIC, OR MEDICAL PRODUCT
